| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |